Ifm Investors Pty LTD Abb Vie Inc. Transaction History

Ifm Investors Pty LTD

$10.3 Billion
Q3 2024

A detailed history of Ifm Investors Pty LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Ifm Investors Pty LTD holds 360,544 shares of ABBV stock, worth $63.3 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

360,544

Previous 361,826 0.35%

Holding current value

$63.3 Million

Previous $62.1 Million 14.73%

% of portfolio

0.69%

Previous 0.63%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$163.84 - $199.33 $210,042 - $255,541	-1,282 Reduced 0.35%	360,544 $71.2 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $322,272 - $376,342	2,082 Added 0.58%	361,826 $62.1 Million
Q1 2024 Apr 22, 2024	SELL	$159.82 - $182.1 $215,916 - $246,017	-1,351 Reduced 0.37%	359,744 $65.5 Million
Q4 2023 Jan 12, 2024	BUY	$137.6 - $154.97 $463,987 - $522,558	3,372 Added 0.94%	361,095 $56 Million
Q3 2023 Oct 26, 2023	BUY	$133.59 - $154.65 $1.43 Million - $1.66 Million	10,719 Added 3.09%	357,723 $53.3 Million
Q2 2023 Jul 27, 2023	BUY	$132.51 - $164.9 $2.21 Million - $2.76 Million	16,715 Added 5.06%	347,004 $46.8 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $1.39 Million - $1.6 Million	9,628 Added 3.0%	330,289 $52.6 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $1.78 Million - $2.14 Million	12,893 Added 4.19%	320,661 $51.9 Million
Q3 2022 Oct 12, 2022	BUY	$134.21 - $153.93 $384,914 - $441,471	2,868 Added 0.94%	307,768 $41.3 Million
Q2 2022 Jul 15, 2022	BUY	$137.62 - $174.96 $2.77 Million - $3.52 Million	20,137 Added 7.07%	304,900 $46.7 Million
Q1 2022 Apr 13, 2022	BUY	$131.98 - $163.75 $6.54 Million - $8.11 Million	49,543 Added 21.06%	284,763 $46.2 Million
Q4 2021 Jan 18, 2022	SELL	$107.43 - $135.93 $69,722 - $88,218	-649 Reduced 0.28%	235,220 $31.8 Million
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $18,407 - $20,894	173 Added 0.07%	235,869 $25.4 Million
Q2 2021 Jul 16, 2021	BUY	$105.21 - $117.21 $4.46 Million - $4.97 Million	42,379 Added 21.92%	235,696 $26.5 Million
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $2.33 Million - $2.56 Million	22,731 Added 13.33%	193,317 $20.9 Million
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $1.9 Million - $2.57 Million	23,636 Added 16.08%	170,586 $18.3 Million
Q3 2020 Oct 16, 2020	BUY	$85.91 - $100.83 $1.47 Million - $1.72 Million	17,075 Added 13.15%	146,950 $12.9 Million
Q2 2020 Jul 13, 2020	SELL	$73.37 - $98.18 $1.29 Million - $1.72 Million	-17,526 Reduced 11.89%	129,875 $12.8 Million
Q1 2020 Apr 09, 2020	SELL	$64.5 - $97.79 $317,598 - $481,517	-4,924 Reduced 3.23%	147,401 $11.1 Million
Q4 2019 Jan 13, 2020	SELL	$72.13 - $90.25 $536,863 - $671,730	-7,443 Reduced 4.66%	152,325 $13.5 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $3.46 Million - $4.16 Million	54,980 Added 52.47%	159,768 $12.1 Million
Q2 2019 Jul 16, 2019	BUY	$65.7 - $83.98 $450,899 - $576,354	6,863 Added 7.01%	104,788 $7.62 Million
Q1 2019 Apr 18, 2019	BUY	$77.14 - $90.79 $786,828 - $926,058	10,200 Added 11.63%	97,925 $7.89 Million
Q4 2018 Jan 23, 2019	BUY	$77.85 - $96.01 $592,905 - $731,212	7,616 Added 9.51%	87,725 $8.09 Million
Q3 2018 Oct 22, 2018	BUY	$88.91 - $98.84 $917,995 - $1.02 Million	10,325 Added 14.8%	80,109 $7.58 Million
Q2 2018 Jul 09, 2018	BUY	$89.78 - $106.23 $1.8 Million - $2.13 Million	20,071 Added 40.37%	69,784 $6.47 Million
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $467,778 - $626,399	5,084 Added 11.39%	49,713 $4.71 Million
Q4 2017 Jan 29, 2018	SELL	$89.56 - $98.21 $7,075 - $7,758	-79 Reduced 0.18%	44,629 $4.32 Million
Q3 2017 Nov 16, 2017	BUY	$69.85 - $89.22 $47,078 - $60,134	674 Added 1.53%	44,708 $3.97 Million
Q2 2017 Aug 10, 2017	BUY	N/A	11,010 Added 33.34%	44,034 $3.19 Million
Q1 2017 Aug 17, 2017	BUY	N/A	33,024	33,024 $2.15 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.

Account

Ifm Investors Pty LTD Abb Vie Inc. Transaction History